Active Ingredient: TRANEXAMIC ACID
Proprietary Name: TRANEXAMIC ACID
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 1GM/100ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N212020
Product Number: 001
Approval Date: Apr 15, 2019
Applicant Holder Full Name: EXELA PHARMA SCIENCES LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
